Aristeia Capital’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Aristeia Capital’s Portfolio DRTSW Stock Details DRTSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$533K	Buy	+543,500	New	+$523K	0.01%	355

Other funds holding DRTSW

Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Value Base Tel Aviv, Israel $127M AUM 12.37% 1-Year Est. Return

Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Aristeia Capital's DRTSW Position: Q1 2026 in Review

Aristeia Capital opened a new position in Alpha Tau Medical Warrant (DRTSW) in Q1 2026: 543,500 shares worth $533K. The stake represents 0.01% of the portfolio and ranks #355 among its holdings.

21 funds tracked by Wall St. Rank hold DRTSW as of Q1 2026.

Aristeia Capital held 543,500 shares of Alpha Tau Medical Warrant worth $533K as of Q1 2026.
Alpha Tau Medical Warrant was a new Aristeia Capital position in Q1 2026.
Alpha Tau Medical Warrant made up 0.01% of Aristeia Capital's portfolio in Q1 2026, its #355 holding.
21 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q1 2026.

Based on Aristeia Capital's 13F filing for Q1 2026, filed 15 May 2026.